Gelteq Ltd
GELS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001920092
No open-market purchases or sales by Gelteq Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.3K in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Gelteq Ltd changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 3 | 5 | +2 |
| Shares | 85.3K | 62.4K | −22.9K (−26.9%) |
| Value | $68.1K | $40.9K | −$27.2K (−40.0%) |
New holders (3)
Institutions that held Gelteq Ltd at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Private Advisor Group, LLC | 16,668 | $11.0K | 0.00% |
| Citadel Advisors LLC | 13,830 | $8.99K | 0.00% |
| UBS Group AG | 1,834 | $1.21K | 0.00% |
Sold out (1)
Institutions that held Gelteq Ltd at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Virtu Financial LLC | 13,953 | $11.0K |